HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
GABRA6
gamma-aminobutyric acid type A receptor subunit alpha6
Chromosome 5 · 5q34
NCBI Gene: 2559Ensembl: ENSG00000145863.11HGNC: HGNC:4080UniProt: Q16445
51PubMed Papers
20Diseases
72Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Ion ChannelReceptorTransporter
CLINICAL
FDA Approved Target
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
synaptic transmission, GABAergicpostsynapsepostsynaptic specialization membraneGABA-A receptor complexinsomniaepilepsymajor depressive disordermigraine disorder
✦AI Summary

GABRA6 encodes the alpha-6 subunit of GABA(A) receptors, ligand-gated chloride channels that mediate inhibitory neurotransmission in the brain 1. The subunit assembles into heteropentameric complexes containing GABA binding sites at alpha-beta interfaces; GABA activation opens the central pore to allow chloride influx, hyperpolarizing neurons and suppressing action potential generation 1. Alpha-6 subunits localize to both synaptic and extrasynaptic sites, where they contribute to tonic GABAergic inhibition 1. Genetic variants in GABRA6 have substantial clinical relevance. The rs3219151 T allele associates with increased hypothalamic-pituitary-adrenal axis activation during psychological stress, elevated cortisol and ACTH responses, and reduced extraversion 2. In stressed individuals, this allele increases anxiety, depression, and suicide-related phenotypes including suicidal ideation, hopelessness, and insomnia 3. Multiple polymorphisms (rs3219151, c.1512T>C, c.1344C>G) confer idiopathic generalized epilepsy susceptibility in diverse populations 456, and rare variants increase bipolar disorder risk 7. The 1519T>C polymorphism associates with hypercortisolism and abdominal obesity 8. These findings establish GABRA6 as a critical regulator of stress responses and seizure susceptibility with implications for neuropsychiatric disease risk.

Sources cited
1
GABRA6 encodes an alpha subunit of heteropentameric GABA(A) chloride channels; alpha-6 subunits localize to synaptic and extrasynaptic sites
PMID: 8632757
2
GABRA6 rs3219151 T allele associates with greater ACTH, cortisol, and blood pressure responses to psychological stress; C allele carriers show lower extraversion
PMID: 15197399
3
GABRA6 rs3219151 T allele increases anxiety, depression, and suicide-related thoughts/behaviors in individuals exposed to recent negative life events
PMID: 29018204
4
GABRA6 mutations (rs3219151 and novel c.1344C>G) associate with idiopathic generalized epilepsy in Pakistani patients
PMID: 34740144
5
GABRA6 rs3219151 CC genotype and C allele significantly associated with idiopathic generalized epilepsy in South Indian population
PMID: 25088614
6
GABRA6 c.1512T>C polymorphism confers epilepsy susceptibility risk in North Indian population
PMID: 21420396
7
Rare variants in GABRA6, including missense variants, contribute to bipolar disorder genetic risk through altered neuronal excitability
PMID: 25730879
8
GABRA6 1519T>C polymorphism associates with higher cortisol secretion and abdominal obesity
PMID: 12080446
Disease Associationsⓘ20
insomniaOpen Targets
0.62Moderate
epilepsyOpen Targets
0.62Moderate
major depressive disorderOpen Targets
0.61Moderate
migraine disorderOpen Targets
0.61Moderate
panic disorderOpen Targets
0.60Moderate
anxiety disorderOpen Targets
0.60Moderate
AgitationOpen Targets
0.60Moderate
AnxietyOpen Targets
0.60Moderate
alcohol dependenceOpen Targets
0.60Moderate
SeizureOpen Targets
0.59Moderate
postpartum depressionOpen Targets
0.58Moderate
PainOpen Targets
0.57Moderate
status epilepticusOpen Targets
0.57Moderate
generalized anxiety disorderOpen Targets
0.56Moderate
HeadacheOpen Targets
0.55Moderate
Lennox-Gastaut syndromeOpen Targets
0.55Moderate
depressive disorderOpen Targets
0.54Moderate
Stiff-Person syndromeOpen Targets
0.53Moderate
partial epilepsyOpen Targets
0.51Moderate
sedationOpen Targets
0.51Moderate
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Drug Targets72
ABP-700Phase II
GABA-A receptor; anion channel agonist
ACAMPROSATEApproved
Glutamate [NMDA] receptor antagonist
alcohol dependence
ACAMPROSATE CALCIUMApproved
Glutamate [NMDA] receptor antagonist
alcohol dependence
ADIPIPLONPhase II
GABA-A receptor; anion channel partial agonist
sleep-wake disorder
ALPRAZOLAMApproved
GABA-A receptor; anion channel positive allosteric modulator
panic disorder
BREXANOLONEApproved
GABA-A receptor; anion channel positive allosteric modulator
BUTABARBITALApproved
GABA-A receptor; anion channel positive allosteric modulator
insomnia
BUTALBITALApproved
GABA-A receptor; anion channel positive allosteric modulator
migraine disorder
CENOBAMATEApproved
Sodium channel alpha subunit inhibitor
Seizure
CHLORDIAZEPOXIDEApproved
GABA-A receptor; anion channel positive allosteric modulator
anxiety disorder
CHLORDIAZEPOXIDE HYDROCHLORIDEApproved
GABA-A receptor; anion channel positive allosteric modulator
CIPEPOFOLPhase III
GABA-A receptor; anion channel agonist
CLOBAZAMApproved
GABA-A receptor; anion channel positive allosteric modulator
CLOMETHIAZOLEPhase III
GABA-A receptor; anion channel positive allosteric modulator
stroke
CLONAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
CLORAZEPATE DIPOTASSIUMApproved
GABA-A receptor; anion channel positive allosteric modulator
CLORAZEPIC ACIDApproved
GABA-A receptor; anion channel positive allosteric modulator
anxiety disorder
CLOTIAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
anxiety disorder
DARIGABATPhase II
GABA-A receptor; anion channel agonist
Chronic pain
DESFLURANEApproved
Potassium channel subfamily K member 10 opener
DIAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
Agitation
ENFLURANEApproved
Potassium channel subfamily K member 10 opener
ESTAZOLAMApproved
GABA-A receptor; anion channel positive allosteric modulator
insomnia
ESZOPICLONEApproved
GABA-A receptor; anion channel positive allosteric modulator
insomnia
ETHCHLORVYNOLApproved
GABA-A receptor; anion channel positive modulator
insomnia
ETIFOXINEApproved
GABA-A receptor; anion channel antagonist
Anxiety
ETOMIDATEApproved
GABA-A receptor; anion channel positive modulator
FLUMAZENILApproved
GABA-A receptor; anion channel allosteric antagonist
FLUNITRAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
insomnia
FLURAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
insomnia
FLURAZEPAM HYDROCHLORIDEApproved
GABA-A receptor; anion channel positive allosteric modulator
GANAXOLONEApproved
GABA-A receptor; anion channel positive allosteric modulator
epilepsy
GLUTETHIMIDEApproved
GABA-A receptor; anion channel positive modulator
insomnia
HALAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
anxiety disorder
HALOTHANEApproved
Potassium channel subfamily K member 10 opener
ISOFLURANEApproved
Potassium channel subfamily K member 2 opener
LORAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
major depressive disorder
MEPROBAMATEApproved
GABA-A receptor; anion channel agonist
anxiety disorder
METHAQUALONEUNKNOWN
GABA-A receptor; anion channel positive allosteric modulator
insomnia
METHAQUALONE HYDROCHLORIDEUNKNOWN
GABA-A receptor; anion channel positive allosteric modulator
METHARBITALApproved
GABA-A receptor; anion channel positive allosteric modulator
epilepsy
METHOHEXITALApproved
GABA-A receptor; anion channel positive allosteric modulator
METHOXYFLURANEApproved
GABA-A receptor; anion channel positive modulator
METHYPRYLONApproved
GABA-A receptor; anion channel positive allosteric modulator
insomnia
MIDAZOLAMApproved
GABA-A receptor; anion channel positive allosteric modulator
epilepsy
MIDAZOLAM HYDROCHLORIDEApproved
GABA-A receptor; anion channel positive allosteric modulator
amnesia
OXAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
Agitation
PADSEVONILPhase II/III
GABA-A receptor; anion channel partial agonist
epilepsy
PAGOCLONEPhase II/III
GABA-A receptor; anion channel positive allosteric modulator
anxiety disorder
PENTOBARBITALApproved
GABA-A receptor; anion channel positive allosteric modulator
insomnia
PENTOBARBITAL SODIUMUNKNOWN
GABA-A receptor; anion channel positive allosteric modulator
PRAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
anxiety disorder
PRIMIDONEApproved
GABA-A receptor; anion channel positive allosteric modulator
epilepsy
PROPOFOLApproved
GABA-A receptor; anion channel positive allosteric modulator
QUAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
REMIMAZOLAMApproved
GABA-A receptor; anion channel positive allosteric modulator
REMIMAZOLAM BESYLATEApproved
GABA-A receptor; anion channel positive allosteric modulator
RESEQUINILPhase II
GABA-A receptor; anion channel inverse agonist
epilepsy
SECOBARBITALApproved
GABA-A receptor; anion channel positive allosteric modulator
SECOBARBITAL SODIUMUNKNOWN
GABA-A receptor; anion channel positive allosteric modulator
SEVOFLURANEApproved
Glycine receptor (alpha-1/beta) positive modulator
TALBUTALApproved
GABA-A receptor; anion channel positive allosteric modulator
Irritability
TEMAZEPAMApproved
GABA-A receptor; anion channel positive allosteric modulator
insomnia
TETRAZEPAMUNKNOWN
GABA-A receptor; anion channel positive allosteric modulator
THIAMYLALApproved
GABA-A receptor; anion channel positive allosteric modulator
THIOPENTALApproved
GABA-A receptor; anion channel positive allosteric modulator
THIOPENTAL SODIUMPhase I
GABA-A receptor; anion channel positive allosteric modulator
amnesia
TOPIRAMATEApproved
Glutamate receptor ionotropic AMPA antagonist
epilepsy
TRIAZOLAMApproved
GABA-A receptor; anion channel positive allosteric modulator
TRICLOFOS SODIUMApproved
GABA-A receptor; anion channel positive modulator
insomnia
ZOPICLONEApproved
GABA-A receptor; agonist GABA site positive allosteric modulator
insomnia
ZURANOLONEApproved
GABA-A receptor; anion channel positive allosteric modulator
postpartum depression
Related Genes
GABARAPProtein interaction96%GABARAPL1Protein interaction95%PLCL1Protein interaction91%NSFProtein interaction91%HAP1Protein interaction90%TRAK2Protein interaction90%
Tissue Expression6 tissues
Brain
100%
Bone Marrow
4%
Liver
0%
Heart
0%
Ovary
0%
Lung
0%
Gene Interaction Network
Click a node to explore
GABRA6GABARAPGABARAPL1PLCL1NSFHAP1TRAK2
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q16445
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
1.18LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.92 [0.72–1.18]
RankingsWhere GABRA6 stands among ~20K protein-coding genes
  • #8,677of 20,598
    Most Researched51
  • #30of 1,025
    FDA-Approved Drug Targets58 · top 5%
  • #12,426of 17,882
    Most Constrained (LOEUF)1.18
Genes detectedGABRA6
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients.
PMID: 34740144
Seizure · 2021
1.00
2
GABRA6 gene polymorphism and an attenuated stress response.
PMID: 15197399
Mol Psychiatry · 2004
0.90
3
A new stress sensor and risk factor for suicide: the T allele of the functional genetic variant in the GABRA6 gene.
PMID: 29018204
Sci Rep · 2017
0.80
4
Rare variants in neuronal excitability genes influence risk for bipolar disorder.
PMID: 25730879
Proc Natl Acad Sci U S A · 2015
0.70
5
Association of GABRA6 1519 T>C (rs3219151) and Synapsin II (rs37733634) gene polymorphisms with the development of idiopathic generalized epilepsy.
PMID: 25088614
Epilepsy Res · 2014
0.60